ConductScience.org, home

Gene · 6278

S100A7: S100 calcium binding protein A7

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. S100A7: S100 calcium binding protein A7. Genes, record 6278. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6278

On this page

Gene

Symbol
S100A7
HGNC
Name
S100 calcium binding protein A7
HGNC
NCBI Gene ID
6278
NCBI Gene
HGNC ID
HGNC:10497
HGNC
Ensembl
ENSG00000143556
NCBI Gene
Aliases
PSOR1, S100A7c
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
P31151Protein S100-A71018Ensembl, GeneID, HGNC

Source UniProt

Patents49

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1462556P31151Espacenet
JP 2026004568 A2026-01-1462557P31151Espacenet
US 12023385 B22024-07-0238P31151Espacenet
US 11988676 B22024-05-2157P31151Espacenet
EP 4368629 A12024-05-1566P31151Espacenet
JP 2024038290 A2024-03-1957P31151Espacenet
JP 2023531521 A2023-07-2457P31151Espacenet
US 11622963 B22023-04-112P31151Espacenet
EP 4119552 A12023-01-1852P31151Espacenet
WO 2023282293 A2023-01-1266P31151Espacenet

1 to 10 of 49

See all 49 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants870

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleS100A7 papersNewest fiscal year
P30AR075043University of Michigan Skin Biology and Diseases Resource-based Center92025
P30CA016672Cancer Center Support Grant92025
UL1TR001866Developing, Demonstrating, and Disseminating Innovative Programs to Achieve Translational Success92025
R01GM118695Bioinorganic Explorations of Host-defense Proteins82025
P30AR075049Northwestern University Skin Biology and Diseases Resource-based Center62025
R01AI022553Molecular Analysis of Host Immune Response in Leprosy52025
R01AI127793Neisseria gonorrhoeae metal transporters that subvert nutritional immunity52025
R01AR040312CD1-restricted T-cell Responses in Skin52025
T32AR007197Training Grant in Cell and Molecular Dermatology52025
P30CA008748Cancer Center Support Grant42025

1 to 10 of 870Source NIH's project files

See all 870 nih grants

Papers2,053

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Inhibiting HuR-Mediated mRNA Stabilization Attenuates Psoriasis-Like Inflammation in Preclinical Models.Psoriasis (Auckl)202642769763PubTator, text miningPubMed
Herring roe oil exerts immunomodulatory effects on the IL-17/23 signaling axis in immune and skin cells as models for psoriasis.Front Med (Lausanne)202642707987PubTator, text miningPubMed
SUMOylation-Driven Subtype Heterogeneity and Prognostic Biomarkers in Renal Cell Carcinoma.Curr Issues Mol Biol202642651750PubTator, text miningPubMed
Proteomic Tear Fluid Analysis in Acute Anterior Uveitis Reveals Distinct Characteristics During Active Inflammation.Ocul Immunol Inflamm202642605717PubTator, text miningPubMed
Antimicrobial Peptides of the Skin: Roles in Skin Cancer and Clinical Applications.Exp Dermatol202642576411PubTator, text miningPubMed
Combined Analysis of scRNA-seq and Bulk RNA-seq Sequencing Revealing the Heterogeneity of Recurrent Respiratory Papillomatosis and Key Molecular Mechanisms of Its Occurrence and Development.J Voice202642509150PubTator, text miningPubMed
Identification of novel serum proteins that distinguish idiopathic recurrent aphthous stomatitis from Behcet's disease.PeerJ202642472304PubTator, text miningPubMed
Identification of Bone Marrow and Peripheral Blood Plasma Extracellular Vesicle Protein Biomarker Signatures for Multiple Myeloma Diagnosis and Staging.Int J Nanomedicine202642371508PubTator, text miningPubMed
Biomarker-based machine learning for malignant transformation in oral potentially malignant disorders: a scoping review.BMC Oral Health202642365263PubTator, text miningPubMed
Shared molecular mechanisms of vascular endothelial cells in psoriasis and diabetes comorbidity.Postepy Dermatol Alergol202642222449PubTator, text miningPubMed

1 to 10 of 2,053

See all 2,053 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/6278

GET https://conductscience.org/api/genes/v1/6278/patents?page=2